Showing results (81-90 of 343) with videos related to
Sort By:
Pageof 35
Diabetes/Metabolism Research and Reviews|February 17, 2018
Glucose effectiveness is a critical pathogenic factor leading to glucose intolerance and type 2 diabetes: An ignored hypothesisF P Alford, J E Henriksen, C Rantzau, et al.Diabetes Research and Clinical Practice|March 1, 1985
Increased insulin binding is not involved in the improved insulin effectiveness of gestational diabetics after hypoenergetic dietingO Pedersen, H Beck-Nielsen, B Richelsen, et al.Diabetologia|February 3, 1998
Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patientsJ E Henriksen, F Alford, G M Ward, et al.Clinical Chemistry and Laboratory Medicine|May 15, 2001
Calibration, specificity and trueness of a postheparin plasma lipoprotein lipase assayF L Henriksen, P H Petersen, H Beck-Nielsen, et al.Diabetes Research (Edinburgh, Scotland)|November 1, 1987
Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patientsJ F Bak, O H Nielsen, O Pedersen, et al.British Journal of Audiology|February 3, 2000
Prevalence of hearing impairment and subjective hearing problems in a rural Danish population aged 31-50 yearsB Karlsmose, T Lauritzen, A ParvingEuropean Journal of Endocrinology|October 7, 2000
The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patientsD Worm, J Vinten, A Vaag, et al.Obstetrics and Gynecology|August 1, 1993
Insulin receptor binding and tyrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetesP Damm, A Handberg, C Kühl, et al.Metabolism: Clinical and Experimental|January 1, 1996
Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity techniqueO Hother-Nielsen, J E Henriksen, J J Holst, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1990
Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitusA Vaag, K D Pedersen, M Lauritzen, et al.Pageof 35